跳至主要内容
临床试验/IRCT20230816059167N1
IRCT20230816059167N1招募中3 期

Investigating the effect of probiotic supplements on hyperbilirubinemia in term neonates

Kashan University of Medical Sciences0 个研究点目标入组 81 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
入组人数
81

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
1 day 至 14 days(—)
性别
All

入选标准

  • 35 to 42 weeks of gestation
  • Birth weight between 10th and 90th percentile
  • Newborns aged from birth to 14 days
  • Hyperbilirubinemia based on Bhutani Nomogram

排除标准

  • Unwillingness to cooperate (lack of parental consent)
  • Taking antibiotics
  • Any acute or active infection
  • Occurrence of any side effects
  • Not consuming breast milk exclusively
  • Thyroid disorders
  • Presence of respiratory distress
  • NICU admission
  • Congenital heart disease
  • The presence of hemolysis, hemoglobinopathies, and hemolytic blood diseases such as G6PD deficiency, blood group incompatibility
  • Cephal hematoma and subgaleal hemorrhage
  • Phenobarbital consumption by the mother in the last month of pregnancy
  • Non-physiological hyperbilirubinemia
  • Presence of a life-threatening congenital disorder
  • Blood exchange
  • Outpatient treatment

研究者

相似试验